Overview

Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to investigate the safety, tolerability and pharmacokinetics (exposure in the body) of liraglutide-depot in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide